Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Katsuo Hatayama is active.

Publication


Featured researches published by Katsuo Hatayama.


FEBS Letters | 1991

Novel epoxysuccinyl peptides Selective inhibitors of cathepsin B, in vitro

Mitsuo Murata; Satsuki Miyashita; Chihiro Yokoo; Musaharu Tamai; Kazunori Hanada; Katsuo Hatayama; Takae Towatari; Takeshi Nikawa; Nobuhiko Katunuma

A series of new epoxysuccinyl peptides were designed and synthesized to develop a specific inhibitor of cathepsin B. Of these compounds, N‐(L‐3‐trans‐ethoxycarbonyloxirane‐2‐carbonyl)‐L‐isoleucyl‐L‐proline (compound CA‐030) and N‐(L‐3‐trans‐propylcarbamoyloxirane‐2‐carbonyl)‐L‐isoleucyl‐L‐proline (compound CA‐074) were the most potent and specific inhibitors of cathepsin B in vitro. The carboxyl group of proline and the ethyl ester group or n‐propylamide group in the oxirane ring were necessary, the ethyl ester group or the n‐propylamide group being particularly effective for distinguishing cathepsin B from other cysteine proteinases such as cathepsins L and H, and calpains.


Tetrahedron Letters | 1993

Stereochemistry of the 2-hydroxy-1,2,3,4-tetrahydropyridine intermediate of hantzsch cyclization

Toshihisa Ogawa; Keita Matsumoto; Misa Yoshimura; Katsuo Hatayama; Kunihiro Kitamura; Yasuyuki Kita

Abstract Hantzsch cyclization of cyanoethyl 3-aminocrotonate and (E,Z)-4-dialkoxymethyl-2-benzylidene-acetoacetates (5a,b) afforded 3,4-trans-2-hydr


Journal of The Chemical Society-perkin Transactions 1 | 1993

Synthesis and configurational assignment of methyl 3-nitrooxypropyl 1,4-dihydro-2,6-dimethyl-4-(3-nitrophenyl)pyridine-3,5-dicarboxylate

Toshihisa Ogawa; Keita Matsumoto; Chihiro Yokoo; Katsuo Hatayama; Kunihiro Kitamura

Enantiomeric (+)- and (–)-methy3-nitrooxypropyl 1,4-dihydro-2,6-dimethyl-4-(3- nitrophenyl) pyridine-3,5-dicarboxylate 1 were synthesized by esterification of the optically active monocarboxylic acids (+)-6 and (–)-6, which are available from racemate (±)-6 by optical resolution using cinchonidine and cinchonine. The absolute configuration of the key intermediates (S)-(+)-6 and (R)-(–)-6, was also unambiguously determined by the comparison with optical active (+)- and (–)-1 derived from (R)-(–)- and (S)-(+)-7 and (+)- and (–)-6, and X-ray crystallographic analysis of bromoethyl ester (R)-(–)-8 prepared from the acid (S)-(+)-7.


Journal of The Chemical Society-perkin Transactions 1 | 1993

Chemistry of Hantzsch cyclization: stereochemistry of the 2-hydroxy-1,2,3,4-tetrahydropyridine intermediate of Hantzsch cyclization. X-Ray molecular structure of diastereoisomers of 5-(2-cyanoethyl) 3-methyl 2-dimethoxymethyl-2-hydroxy-6-methyl-4-(3-nitrophenyl)-1,2,3,4-tetrahydropyridine-3,5-dicarboxylates

Toshihisa Ogawa; Keita Matsumoto; Katsuo Hatayama; Kunihiro Kitamura; Yasuyuki Kita

Hantzsch cyclization of cyanoethyl 3-aminocrotonate and (E,Z)-4,4-dialkoxy-2-benzylideneacetoacetates 12a–h afforded the corresponding 3,4-trans-2-hydroxy-1,2,3,4-tetrahydropyridines 14a–h with high stereoselectivity. 1H NMR and X-ray analyses of compound 14a established the configuration of 3-H and 4-H as trans and that of 3-H and 2-OH as trans also.


Archive | 1989

2-Azetidinone derivatives

Yutaka Kawashima; Masakazu Sato; Masahiro Kawase; Yoshiaki Watanabe; Katsuo Hatayama


Archive | 1993

5-o-desosaminylerythronolide a derivative

Toshifumi Asaka; Masato Kashimura; Yoko Misawa; Shigeo Morimoto; Katsuo Hatayama


Archive | 1995

Quinolinecarboxylic acid derivatives

Yutaka Ohuchi; Masaji Suzuki; Hajime Asanuma; Sadakazu Yokomori; Katsuo Hatayama


Chemical & Pharmaceutical Bulletin | 1979

Anti-ulcer effect of isoprenyl flavonoids. II. Synthesis and anti-ulcer activity of new chalcones related to sophoradin.

Kazuaki Kyogoku; Katsuo Hatayama; Sadakazu Yokomori; Ryuichi Saziki; Sadao Nakane; Michitada Sasajima; Jiro Sawada; Masahiro Ohzeki; Ichiro Tanaka


Journal of Medicinal Chemistry | 1993

Synthesis and pharmacological evaluation of (nitrooxy)alkyl apovincaminates

Yutaka Kawashima; Tomoyuki Ikemoto; Akiyo Horiguchi; Masatoshi Hayashi; Keita Matsumoto; Kimiko Kawarasaki; Ryuzaburo Yamazaki; Shigeru Okuyama; Katsuo Hatayama


Archive | 1991

6-0-methylerythromycin A derivatives

Masato Kashimura; Toshifumi Asaka; Shigeo Morimoto; Katsuo Hatayama

Collaboration


Dive into the Katsuo Hatayama's collaboration.

Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar

Shigeo Morimoto

Taisho Pharmaceutical Co.

View shared research outputs
Top Co-Authors

Avatar

Toshifumi Asaka

Taisho Pharmaceutical Co.

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar

Yoko Misawa

Taisho Pharmaceutical Co.

View shared research outputs
Top Co-Authors

Avatar

Kazuaki Kyogoku

Taisho Pharmaceutical Co.

View shared research outputs
Top Co-Authors

Avatar

Manki Komatsu

Taisho Pharmaceutical Co.

View shared research outputs
Top Co-Authors

Avatar

Ichiro Tanaka

Taisho Pharmaceutical Co.

View shared research outputs
Top Co-Authors

Avatar
Researchain Logo
Decentralizing Knowledge